Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RNA
#1652
Avidity Biosciences, Inc. Common Stock
14.750
0
-79.74%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
-79.74%
Mudança mensal
-79.67%
Mudança em 6 meses
-79.03%
Mudança anual
-79.03%
Fechamento anterior
72.800
0
Open
14.750
0
Bid
Ask
Low
14.750
0
High
14.750
0
Volume
25
Mercados
Ações
Cuidados de saúde
RNA
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
37.58 M
47.75 M
70.81 M
79.72 M
120.21 M
155.15 M
—
Valuation ratios
Enterprise value
637.7 M
814.68 M
1.09 B
545.15 M
3.28 B
10.81 B
23.74 B
Price to earnings ratio
-0.07
-0.01
-6.06
-3.15
-10.06
-14.51
-42.81
Price to sales ratio
-0.46
-0.09
114.51
69.96
297.77
529.62
1 512.55
Price to cash flow ratio
-0.08
-0.01
7.75
5.62
10.78
15.27
41.94
Price to book ratio
-0.01
-0
1.83
1.34
2.28
5.88
8.1
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.13
-0.28
-0.27
-0.34
-0.21
-0.35
-0.4
Return on equity %
-0.14
-0.31
-0.3
-0.42
-0.23
-0.41
-0.45
Return on invested capital %
-1 954.4
-2 299.28
-2 129.73
-1 908.04
-2 666.54
-372.86
—
Gross margin %
100
100
100
100
100
100
400
Operating margin %
-652.38
-1 265.83
-1 939.65
-2 464.41
-3 477.43
-3 977.3
-43.91 K
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
-653.53
-1 265.38
-1 886.33
-2 219.87
-2 957.71
-3 650.39
-40.42 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
22.74
13.86
12
7.58
15.73
9.2
46.94
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.02
0.02
0.02
0.02
0.01
0.01
0.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.01
—
—
—
—
—
—
Long term debt to total equity ratio
0.01
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
301.07
2 821.82
-2.61
-1.63
-2.7
-4.72
-4.92
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
-2 661.31
-12.07 K
11.71
8.15
13.44
2.78
25.53
Net current asset value per share
-2 690.34
-12.24 K
11.94
8.37
13.82
13.06
48.69
Tangible book value per share
-2 483.86
-11.35 K
11.08
6.86
12.77
12.26
46.02
Working capital per share
-2 572.02
-11.35 K
10.95
7.27
12.94
11.64
44.28
Book value per share
-2 483.86
-11.35 K
11.08
6.86
12.77
12.26
46.02
Notícias
Morning News Wrap-Up 2/27/26: Today’s Biggest Stock Market Stories! - TipRanks.com
Lucro da Avidity Bio veio abaixo das projeções por $0,30; receita menor do que estimativas
Avidity Bio earnings missed by $0.30, revenue fell short of estimates
Avidity adia assembleia de acionistas e define novas datas para fusão
Avidity postpones stockholder meeting, sets merger dates
BB Biotech apresenta lucro 660% maior em 2025, mas projeta cautela para 2026
Avidity’s myotonic dystrophy drug shows promising results in trial
F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine
Vaccine Makers Curtail Research and Cut Jobs
U.S. Health Officials Defend Rejection of Moderna’s Flu Vaccine
F.D.A. Refuses to Review Moderna Flu Vaccine
Novartis Beats on Q4 Earnings, Entresto Generics Pressure Sales